Sixty alcoholic patients with depressive disorders completed a 12-week
, open-label trial of imipramine; 27 (45%) had a favorable response, d
efined as substantial improvement in both mood and sobriety. The autho
rs examine demographic and clinical predictors of response. Responders
were less likely to be minorities, had Cower Hamilton Rating Scale fo
r Depression scores, fewer maximum drinks per day at baseline, and wer
e somewhat more likely to have panic disorder The authors discuss impl
ications for the selection of alcoholic patients for antidepressant tr
eatment.